Atovaquone
NDC Package 66689-062-18

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). Marketed by Vistapharm, Llc, this product is identified by NDC 66689-062 and is authorized under FDA application ANDA202960.

Identification & Billing

NDC Package Code
66689-062-18
Package Description
18 POUCH in 1 CASE / 5 mL in 1 POUCH (66689-062-01)
Product Code
66689-062
11-Digit Billing Format
66689006218
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Atovaquone
Dosage Form
-
Usage Information
Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath.

Regulatory & Marketing

Labeler Name
Vistapharm, Llc
FDA Application #
ANDA202960
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-14-2018
End Marketing Date
07-11-2024
Listing Expiration
07-11-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (66689-062). Click a package code to view its specific billing and regulatory data.

66689-062-42
42 POUCH in 1 CASE / 5 mL in 1 POUCH (66689-062-01)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66689-062-18 identifies a specific commercial package of 18 pouch in 1 case / 5 ml in 1 pouch (66689-062-01) of Atovaquone, labeled by Vistapharm, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Vistapharm, Llc on September 14, 2018. The current certification is valid through July 11, 2024.

What are the primary indications for this medication?

Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath.

How is this Vistapharm, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66689006218. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66689-062-18
11-Digit CMS (5-4-2)
66689-0062-18

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.